Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Cerulean Pharma Cmn (CERU)

Cerulean Pharma Cmn (CERU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Cerulean Pharma Cmn 35 GATEHOUSE DRIVE WALTHAM MA 02451 USA

www.ceruleanrx.com P: 781-996-4300

Description:

Cerulean Pharma Inc. is a clinical-stage oncology-focused company. The Company manufactures therapeutics in the areas of oncology, cardiovascular, autoimmune, and inflammatory diseases as well as tumor cells. Cerulean Pharma Inc. is based in Cambridge, Massachusetts.

Key Statistics

Overview:

Market Capitalization, $K 19,160
Shares Outstanding, K 29,030
Annual Sales, $ 770 K
Annual Net Income, $ -39,310 K
Last Quarter Sales, $ 1,190 K
Last Quarter Net Income, $ -6,340 K
60-Month Beta 2.65
% of Insider Shareholders 28.60%
% of Institutional Shareholders 21.63%

Growth:

1-Year Return -77.70%
3-Year Return -86.25%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Latest Earnings Date 08/03/17
Earnings Per Share ttm -0.98
EPS Growth vs. Prev Year 55.10%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

CERU Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -202.95%
Return-on-Assets % -89.43%
Profit Margin % -5,105.20%
Debt/Equity 0.34
Price/Sales 24.10
Price/Cash Flow N/A
Price/Book 2.46
Book Value/Share 0.27
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar